Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Other Non Operating Income (2020 - 2022)

Inventiva (IVA) posted quarterly Other Non Operating Income of $109.7 million for Q4 2024, up 26105.49% year-over-year from N/an in Q1 2024, and up 1297.39% quarter-over-quarter from -$9.2 million in Q2 2024.

Analysis

Inventiva (IVA) Other Non Operating Income (2020 - 2022) Analysis & Trends

Inventiva's Other Non Operating Income history runs 4 years deep, the most recent figure standing at $109.7 million for Q4 2024.

  • In Q4 2024, Other Non Operating Income rose 26105.49% year-over-year to $109.7 million; the TTM figure through Dec 2024 stood at $109.7 million (up 26105.49% YoY), while the FY2024 annual figure was $109.7 million, up 26105.49% from the prior year.
  • Other Non Operating Income for Q4 2024 stood at $109.7 million, up from -$9.2 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $109.7 million in Q4 2024, with the low at -$9.2 million in Q2 2024.
  • The 4-year median for Other Non Operating Income is $7727.6 (2020), against an average of $14.4 million.
  • Peak annual rise in Other Non Operating Income reached 26105.49% in 2024, while the deepest fall reached 418.3% in 2024.
  • Inventiva's Other Non Operating Income stood at -$1101.5 in 2020, then surged by 157250.38% to $1.7 million in 2021, then sank by 75.82% to $418540.6 in 2023, then soared by 26105.49% to $109.7 million in 2024.
  • Business Quant data shows IVA's Other Non Operating Income at $109.7 million in Q4 2024, -$9.2 million in Q2 2024, and $418540.6 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Inventiva 893.85 Mn 893.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 4.10 Mn
Sep 22, 2022 1.91 Mn
Dec 31, 2021 -4.42 Mn
Jun 30, 2021 -9.09 Mn
Mar 31, 2021 4.44 Mn
Dec 31, 2020 -751,142.61
Mar 31, 2020 11,039.39